Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.

Albrethsen J, Bøgebo R, Møller CH, Olsen JA, Raskov HH, Gammeltoft S.

Proteomics Clin Appl. 2012 Apr;6(3-4):182-9. doi: 10.1002/prca.201100095.

PMID:
22532454
2.
3.

[Application of serum protein pattern model in diagnosis of colorectal cancer].

Chen YD, Zheng S, Yu JK, Hu X.

Zhonghua Zhong Liu Za Zhi. 2004 Jul;26(7):417-20. Chinese.

PMID:
15355647
5.

[Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].

Lai YH, Xu JM, Yu XZ, Zhong YS, Wei Y, Ren L, Zhu DX, Liu YK, Niu WX, Qin XY.

Zhonghua Wai Ke Za Zhi. 2008 Jul 1;46(13):995-7. Chinese.

PMID:
19035201
6.

Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.

Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.

J Zhejiang Univ Sci B. 2006 Mar;7(3):235-40.

7.

[Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics].

Chen YD, Xie PP, Yu JW, Zhou J, Zheng S.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):470-7. Chinese.

PMID:
19830859
8.

[Application of serum proteomic mass spectrum analysis in breast cancer].

Ying MG, Chen Q, Ye YB, Chen HJ, Chen X, Zheng HY, Wu F.

Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):698-702. Chinese.

PMID:
21122387
9.

[Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].

Shi YJ, Zhao Y, Xu JM, Lai YH, Yu XZ, Zhong YS, Wei Y, Ren L, Zhu DX, Liu YK, Niu WX, Qin XY.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):910-3. Chinese.

PMID:
19173991
10.

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH.

Oncol Rep. 2010 Jul;24(1):57-64.

PMID:
20514444
11.

Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.

Zhao L, Liu Y, Sun X, Peng K, Ding Y.

J Comp Pathol. 2011 Feb-Apr;144(2-3):187-94. doi: 10.1016/j.jcpa.2010.09.001. Epub 2010 Nov 12.

PMID:
21074777
12.

Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer.

Ragazzi E, Pucciarelli S, Seraglia R, Molin L, Agostini M, Lise M, Traldi P, Nitti D.

J Mass Spectrom. 2006 Dec;41(12):1546-53.

PMID:
17117375
13.

[Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].

Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.

Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):753-7. Chinese.

PMID:
17366787
14.

SELDI-TOF serum proteomics and colorectal cancer: a current overview.

Gemoll T, Roblick UJ, Auer G, Jörnvall H, Habermann JK.

Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):188-96. doi: 10.3109/13813455.2010.495130. Epub 2010 Jul 8. Review.

PMID:
20615064
15.

Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.

Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H.

Mol Cell Proteomics. 2009 Aug;8(8):1878-90. doi: 10.1074/mcp.M800541-MCP200. Epub 2009 May 20.

16.

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.

Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.

Clin Cancer Res. 2008 Jan 15;14(2):470-7. doi: 10.1158/1078-0432.CCR-07-0586.

17.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H.

J Proteome Res. 2007 Jul;6(7):2495-501. Epub 2007 Jun 2.

PMID:
17542627
18.

[Identification of colorectal cancer using proteomic patterns in serum].

Zhao G, Gao CF, Song GY, Li DH, Wang XL.

Ai Zheng. 2004 Jun;23(6):614-8. Chinese.

PMID:
15191657
19.

Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS.

Zheng GX, Wang CX, Qu X, Deng XM, Deng BP, Zhang J.

Exp Oncol. 2006 Dec;28(4):282-7.

PMID:
17285111
20.

Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.

Chen D, Chen F, Lu X, Yang X, Xu Z, Pan J, Huang Y, Lin H, Chi P.

Int J Oncol. 2010 Aug;37(2):355-65.

PMID:
20596663

Supplemental Content

Support Center